Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 19, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revance Therapeutics, Inc.
| -20.53K |
$5.31 | -$108,927.56 | -2.02% | 994.93K |
Mar 15
| |||||||
Revance Therapeutics, Inc.
| 30K |
$6.98 | $209,400.00 | +3.04% | 1.02M |
Mar 6
| |||||||
Revance Therapeutics, Inc.
| 70.75K |
—
|
—
| +7.73% | 985.47K |
Feb 29
| |||||||
Glaukos Corp
| 5.44K |
$50.08 | -$350,737.20 | +19.58% | 33.22K |
Feb 23
| |||||||
Revance Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 31
| |||||||
Revance Therapeutics, Inc.
| 264 |
$7.47 | $1,972.08 | +0.03% | 914.72K |
Dec 31
| |||||||
Revance Therapeutics, Inc.
| 74.08K |
$18.91 | -$908,890.24 | +8.81% | 914.45K |
Aug 11
| |||||||
Revance Therapeutics, Inc.
| -26.28K |
$22.57 | -$593,151.19 | -3.03% | 840.38K |
Aug 3
| |||||||
Revance Therapeutics, Inc.
| -25.28K |
$20.27 | -$639,726.56 | -2.83% | 866.65K |
Jun 30 - Jul 3
| |||||||
Revance Therapeutics, Inc.
| -31.28K |
$30.72 | -$960,928.41 | -3.39% | 891.93K |
Jun 9
| |||||||
Glaukos Corp
| 3.23K |
—
|
—
| +13.16% | 27.78K |
Jun 1
| |||||||
Revance Therapeutics, Inc.
| 105.2K |
$34.55 | -$2,433,725.46 | +12.86% | 923.21K |
Feb 2 - May 15
| |||||||
Revance Therapeutics, Inc.
| -5.34K |
$30.65 | -$163,701.65 | -0.65% | 818.01K |
Mar 15
| |||||||
Revance Therapeutics, Inc.
| 105.26K |
$31.59 | -$2,223,359.66 | +14.66% | 823.35K |
Sep 22 - Mar 9
| |||||||
Glaukos Corp
| 2.95K |
—
|
—
| +13.65% | 24.55K |
Jan 3
| |||||||
Revance Therapeutics, Inc.
| 605 |
$12.18 | $7,369.20 | +0.08% | 718.09K |
Dec 31
| |||||||
Revance Therapeutics, Inc.
| -49.27K |
$26.97 | -$1,328,919.78 | -6.43% | 717.49K |
Oct 13
| |||||||
Revance Therapeutics, Inc.
| 1K |
$11.75 | $11,747.00 | +0.13% | 766.76K |
Jun 30
| |||||||
Glaukos Corp
| 4.36K |
—
|
—
| +25.32% | 21.6K |
Jun 2
| |||||||
Revance Therapeutics, Inc.
| -3.30K |
$15.79 | -$52,170.16 | -0.43% | 765.76K |
Mar 15
| |||||||
Revance Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 2
| |||||||
Glaukos Corp
| 2.49K |
—
|
—
| +16.85% | 17.24K |
Jan 3
| |||||||
Revance Therapeutics, Inc.
| 40K |
$12.90 | $515,924.00 | +56.41% | 110.91K |
Nov 29
| |||||||
Revance Therapeutics, Inc.
| -42.10K |
$23.08 | -$971,575.68 | -5.19% | 769.07K |
Oct 13
| |||||||
Revance Therapeutics, Inc.
| 882 |
$24.09 | $21,246.50 | +0.11% | 811.16K |
Jun 30
| |||||||
Glaukos Corp
| 2.38K |
—
|
—
| +19.26% | 14.75K |
Jun 3
| |||||||
Revance Therapeutics, Inc.
| 40.72K |
—
|
—
| +5.29% | 810.28K |
Feb 2
| |||||||
Glaukos Corp
| 1.18K |
—
|
—
| +10.58% | 12.37K |
Jan 4
| |||||||
Revance Therapeutics, Inc.
| 249.25K |
$27.62 | -$1,825,847.72 | +42.16% | 840.48K |
Jul 23 - Oct 13
| |||||||
Revance Therapeutics, Inc.
| 157.73K |
$25.14 | -$3,601,782.66 | +38.15% | 571.23K |
Sep 30
| |||||||
Si-Bone, Inc.
| 8.8K |
—
|
—
|
∞
| 8.8K |
Jun 16
| |||||||
Glaukos Corp
| 3.9K |
—
|
—
| +53.53% | 11.19K |
Jun 3
| |||||||
Revance Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Revance Therapeutics, Inc.
| 200K |
—
|
—
| +93.68% | 413.5K |
Jan 23
| |||||||
Revance Therapeutics, Inc.
| 200K |
—
|
—
| +1,481.48% | 213.5K |
Oct 13
| |||||||
Si-Bone, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 13
| |||||||
Si-Bone, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Glaukos Corp
| 2.65K |
—
|
—
| +57.26% | 7.29K |
May 30
| |||||||
Revance Therapeutics, Inc.
| 4.5K |
—
|
—
| +50.00% | 13.5K |
May 9
| |||||||
Glaukos Corp
| 4.63K |
—
|
—
|
∞
| 4.63K |
May 31
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.